Samsrita Labs Limited, a pharmaceutical company based in Hyderabad, Telangana, India, formerly known as Dr Habeebullah Life Sciences Limited, has announced its upcoming board meeting on April 26, 2025. The meeting will address the approval of audited financial results for the quarter and financial year ending March 31, 2025.
Samsrita Labs Limited, a Hyderabad-based pharmaceutical company formerly known as Dr Habeebullah Life Sciences Limited, has formally announced the scheduling of its upcoming board meeting on April 26, 2025. The meeting will take place at 3:30 p.m. at the company’s registered office in Punjagutta, Hyderabad.
The primary agenda includes reviewing and approving the audited financial results for the quarter and financial year ended March 31, 2025. The meeting may also cover additional matters with the chair’s permission.
Samsrita Labs Limited, registered under CIN L85110TG1996PLC09918, is known for its work in the life sciences sector and is listed on both the BSE (Scrip Code: 539267) and the Metropolitan Stock Exchange of India (Symbol: SAMSRITA).
The company’s leadership has reaffirmed its commitment to financial transparency and shareholder value, with Whole-time Director and CFO Mr. K.N.V. Narendra Kumar (DIN: 09223904) overseeing this important phase of corporate reporting.
For more details click here.
